Ignite Creation Date:
2024-05-05 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00157859
Status:
COMPLETED
Last Update Posted:
2005-09-12
First Post:
2005-09-07
Brief Title:
To Evaluate Current Efficacy of Antimalarials Used in Timika Papua Indonesia
Sponsor:
Menzies School of Health Research
Organization:
Menzies School of Health Research
Study Overview
Official Title:
To Evaluate the Efficacy of Chloroquine and SP for Acute Uncomplicated P Falciparum and the Efficacy of Chloroquine for Acute Uncomplicated P Vivax in the Timika Region of Papua Indonesia
Status:
COMPLETED
Status Verified Date:
2005-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Multidrug resistant strains of Pfalciparum and Pvivax are becoming increasingly prevalent in the Asia Pacific rim To determine the efficacy of locally recommended antimalarial protocols in Papua Indonesia consecutive patients presenting to a rural clinic were enrolled into a prospective efficacy study Patients with uncomplicated falciparum malaria were treated with chloroquine plus sulfadoxine-pyrimethamine and those with vivax malaria with chloroquine monotherapy Patients failing therapy received unsupervised oral quinine - doxycycline for 7 days Follow-up was continued for 42 days for falciparum malaria and 28 days for vivax malaria
The study hypothesis was that current recommended antimalarial protocols were no longer effective
The study hypothesis was that current recommended antimalarial protocols were no longer effective
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| Wellcome Trust ME028458MES | None | None | None |